Senior Advisors are previous members of our Executive Team that now serve our organization in an advisory capacity. We are grateful to these committed individuals that are passionate about advancing the mission of the Consulting Club at the Texas Medical Center.
Linhai Zhao, Ph.D.
Linhai is the former President of CCTMC (2017-2018) and he has a Ph.D. degree in Quantitative and Computational Biosciences from Baylor College of Medicine. Before joining Baylor, Linhai obtained his Bachelor’s degree in Bioinformatics from the University of Science and Technology of China. Outside of academia, Linhai participated in several entrepreneurship activities in the Houston area, and also organized the 1st US-China Innovation Summit in Texas as one of the core executive members.
Sanjeev Khatiwada, Ph.D.
Sanjeev is the former Vice President of Education and Events and a current Senior Advisor at CCTMC. His research as a PhD Candidate at Baylor College of Medicine is focused on identifying risk factors that confer susceptibility to the effects of addictive drugs. Sanjeev is also actively involved in Science Policy and Advocacy at both local and national levels.
Before joining BCM, Sanjeev received a BA in Biochemistry & Molecular Biology and BA in Psychology from Cornell College in Iowa. In his free time, Sanjeev enjoys road trips, traveling internationally, keeping up with global and political affairs, reading biographies, and learning about entrepreneurship, history, and philosophy.
Michael McGuire, Ph.D.
Michael joined ClearView Healthcare Partners as a Consultant in September of 2018. He has completed 10+ projects ranging from prioritizing molecular targets for treatment of cancer, inflammatory, and neurological diseases, to conducting a major investigation in the current and future state of gene therapy across five countries and six types of stakeholders. Most recently, Michael is leading a team that seeks to formulate novel business models for improving treatment rates of metabolic disorders.
Michael served as the Vice President for External Relations of CCTMC in 2016-2017. He received his Ph.D. in Cancer Biology from MD Anderson Graduate School of Biomedical Sciences, where he studied DNA methylation dynamics in the tumor microenvironment in the lab of Dr. Anil Sood and resulted in a patent application for inducing demethylation of these regions to stimulate T cell response in tumors. Michael majored in Microbiology, Immunology, and Molecular Genetics during his undergraduate studies at UCLA, conducting prostate cancer research in the Reiter lab at the Geffen School of Medicine.
Jing Jin, Ph.D.
Jing received her Ph.D. from the Department of BioSciences at Rice University. Her Ph.D. research was focused on understanding natural product synthesis in plants. She currently works as a research project manager at Rice University to oversee a large collaborative research grant. She served as the Vice President for the Consulting Agency in 2017-2018, which recruited multiple new clients and completed 6 projects. In her spare time, she enjoys yoga, dance classes, and spending time with her family and two cats.
Jingzhen (Ginger) Ding, Ph.D.
Dr. Ding is the Director of Investment Analyst at MyBioGate. In this role, she leads a team of scientists and consultants to help Chinese companies with their global strategy, focusing on licensing and JV partnership, in healthcare sector. Prior to MyBioGate, Dr. Ding served as Vice President for Finance and Operations of CCTMC (2017-2018) and worked as Postdoc Fellow at MD Anderson Cancer Center. Dr. Ding has a 12-year track record in biomedical research. She was an awardee of Susan G. Komen grant in support of her pre-clinical studies.